EH
BBH icon

Equitable Holdings’s VanEck Biotech ETF BBH Stock Holding History

Equitable Holdings’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
+5,239
New +$985K 0.01% 980
2024
Q4 		– Sell
-1,638
Closed -$291K – 1268
2024
Q3 		$291K Sell
1,638
-30
-2% -$5.32K ﹤0.01% 1052
2024
Q2 		$281K Sell
1,668
-684
-29% -$112K ﹤0.01% 1012
2024
Q1 		$391K Buy
2,352
+870
+59% +$144K ﹤0.01% 890
2023
Q4 		$245K Buy
+1,482
New +$228K ﹤0.01% 998

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Equitable Holdings's BBH Position: Q2 2026 in Review

Equitable Holdings opened a new position in VanEck Biotech ETF (BBH) in Q2 2026: 5,239 shares worth $1.06M. The stake represents 0.01% of the portfolio and ranks #980 among its holdings. This is a return to the name: Equitable Holdings previously reported a position in BBH as recently as Q3 2024.

Equitable Holdings first reported a position in BBH in Q4 2023 and has held it in 5 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • Equitable Holdings held 5,239 shares of VanEck Biotech ETF worth $1.06M as of Q2 2026.
  • VanEck Biotech ETF was a new Equitable Holdings position in Q2 2026.
  • VanEck Biotech ETF made up 0.01% of Equitable Holdings's portfolio in Q2 2026, its #980 holding.
  • Equitable Holdings first reported a position in VanEck Biotech ETF in Q4 2023 and has held it in 5 quarters since.
  • 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.